This finding also raises the possibility that Rg1 and Rb1 treatment may affect BDNF-PI3K/Akt signaling in the PFC, which controls the expression of SYN and PSD95 and thus synaptic plasticity, thus reducing cognitive deficits in the rats. This evidence concerns the gene PPP1R3A and Cognitive impairment.